Discrepancy between Multiparametric Magnetic Resonance Imaging and 68 Ga Prostate-Specific Membrane Antigen Positron Emission Tomography: A Simultaneous Acquired Positron Emission Tomography-Magnetic Resonance Imaging Case.
| Autor: | Moolan NJ; Department of Nuclear Medicine and Molecular Imaging, Amrita Institute of Medical Sciences, Kochi, Kerala, India., Somasundaram VH; Department of Nuclear Medicine and Molecular Imaging, Amrita Institute of Medical Sciences, Kochi, Kerala, India., Rajamma BM; Department of Pathology, Amrita Institute of Medical Sciences, Kochi, Kerala, India., Sundaram PS; Department of Nuclear Medicine and Molecular Imaging, Amrita Institute of Medical Sciences, Kochi, Kerala, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India [Indian J Nucl Med] 2021 Jan-Mar; Vol. 36 (1), pp. 50-52. Date of Electronic Publication: 2021 Mar 04. |
| DOI: | 10.4103/ijnm.IJNM_115_20 |
| Abstrakt: | Conventionally, multiparametric magnetic resonance imaging (mpMRI) incorporating T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences is considered the standard for detection and staging of clinically important prostate cancer (PCa).[1] The 68 gallium ( 68 Ga)-labeled positron emission tomography (PET) tracer targeting prostate-specific membrane antigen (PSMA), 68 Ga-PSMA PET, is a promising tool for detection, localization, and staging carcinoma prostate.[2] Here, we present a case of PCa, showing incongruence between 68 Ga-PSMA PET and the corresponding mpMRI findings. Moreover, the final histopathology revealed a surprise, which exemplifies the complementary nature of combining 68 Ga-PSMA PET and mpMRI in the diagnosis and staging of carcinoma prostate. Competing Interests: There are no conflicts of interest. (Copyright: © 2021 Indian Journal of Nuclear Medicine.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|